BIOACTIVE COMPOUNDS FROM CUPHEA GLUTINOSA CHAM. & SCHLTDL.: PROMISING EFFECTS ON ANTIHYPERTENSIVE ACTION




Challenging clinical management of a patient with Gaucher disease type IIIC homozygous for the D409H mutation, aortic valve calcification and porcelain aorta

Background.Gaucher disease is a rare lysosomal storage disorder caused by glucocerebrosidase enzyme deficiency resulting in the mel axolotl cumulative deposition of glucocerebroside in macrophages, predominantly effecting bone marrow, liver and spleen.Gaucher disease type IIIC is a rare subtype that is characterized by cardiovascular involvement, e

read more